Insights

Acquisition by AstraZeneca Fusion Pharmaceuticals was recently acquired by AstraZeneca for approximately $2.4 billion. This acquisition opens up opportunities for collaboration and cross-selling of products between Fusion and AstraZeneca's extensive network and resources.

Launch of FPI-2265 Fusion Pharmaceuticals has launched FPI-2265, a promising prostate cancer treatment, with plans for Phase 2 and 3 trials. This new product presents a sales opportunity for targeting healthcare providers and institutions specializing in oncology.

Innovative Radiopharmaceutical Technology Fusion Pharmaceuticals utilizes cutting-edge Fast-Clear linker technology to develop next-generation radiopharmaceuticals. This innovative approach enhances precision medicine capabilities, creating potential sales avenues in the oncology sector and beyond.

Strategic Acquisition by EQT EQT Corp's acquisition of Fusion Pharmaceuticals indicates a strategic investment in the biotechnology space. Business development professionals can explore partnership opportunities with EQT and Fusion to leverage the synergy for expanded market reach.

Revenue Growth and Funding With revenue in the range of $0-10 million and recent funding of $60 million, Fusion Pharmaceuticals shows financial stability and growth potential. Sales development representatives can target investors and stakeholders interested in supporting a financially healthy biotech company.

Similar companies to Fusion Pharmaceuticals

Fusion Pharmaceuticals Tech Stack

Fusion Pharmaceuticals uses 8 technology products and services including WooCommerce, Google Font API, Font Awesome, and more. Explore Fusion Pharmaceuticals's tech stack below.

WooCommerce
E-commerce
Google Font API
Font Scripts
Font Awesome
Font Scripts
ADP Workforce Now
Human Capital Management
ADP
Human Resource Management System
Microsoft Azure
Platform As A Service
Linux
Programming Languages
Smartsheet
Project Management

Media & News

Fusion Pharmaceuticals's Email Address Formats

Fusion Pharmaceuticals uses at least 1 format(s):

Fusion Pharmaceuticals Email Formats	Example	Percentage
Last@fusionpharma.com	Doe@fusionpharma.com	88%
FLast@fusionpharma.com	JDoe@fusionpharma.com	8%
First.Last@fusionpharma.com	John.Doe@fusionpharma.com	3%
Middle@fusionpharma.com	Michael@fusionpharma.com	1%

Frequently Asked Questions

Where is Fusion Pharmaceuticals's headquarters located?

Fusion Pharmaceuticals's main headquarters is located at 1280 Main St. West NRB-A316 Hamilton, ON L8S 4K1 CA. The company has employees across 5 continents, including North AmericaAsiaEurope.

What is Fusion Pharmaceuticals's phone number?

You can contact Fusion Pharmaceuticals's main corporate office by phone at

+1-289-799-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fusion Pharmaceuticals's stock symbol?

Fusion Pharmaceuticals is a publicly traded company; the company's stock symbol is FUSN.

What is Fusion Pharmaceuticals's official website and social media links?

Fusion Pharmaceuticals's official website is fusionpharma.com and has social profiles on LinkedIn.

How much revenue does Fusion Pharmaceuticals generate?

As of November 2024, Fusion Pharmaceuticals's annual revenue reached $3.8M.

What is Fusion Pharmaceuticals's SIC code NAICS code?

Fusion Pharmaceuticals's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Fusion Pharmaceuticals have currently?

As of November 2024, Fusion Pharmaceuticals has approximately 123 employees across 5 continents, including North AmericaAsiaEurope. Key team members include Chief Scientific Officer: C. L.Chief Medical Officer: D. B.Chief Technical Officer: E. B.. Explore Fusion Pharmaceuticals's employee directory with LeadIQ.

What industry does Fusion Pharmaceuticals belong to?

Fusion Pharmaceuticals operates in the Biotechnology Research industry.

What technology does Fusion Pharmaceuticals use?

Fusion Pharmaceuticals's tech stack includes WooCommerceGoogle Font APIFont AwesomeADP Workforce NowADPMicrosoft AzureLinuxSmartsheet.

What is Fusion Pharmaceuticals's email format?

Fusion Pharmaceuticals's email format typically follows the pattern of . Find more Fusion Pharmaceuticals email formats with LeadIQ.

How much funding has Fusion Pharmaceuticals raised to date?

As of November 2024, Fusion Pharmaceuticals has raised $60M in funding. The last funding round occurred on Feb 13, 2023 for $60M.

When was Fusion Pharmaceuticals founded?

Fusion Pharmaceuticals was founded in 2014.

Fusion Pharmaceuticals

Biotechnology ResearchOntario, Canada51-200 Employees

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Employing a proprietary Fast-Clear linker technology, Fusion connects alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial.

Fusion is headquartered in Hamilton, ON, with offices in Boston, MA.

Company Overview

Headquarters: 1280 Main St. West NRB-A316 Hamilton, ON L8S 4K1 CA
Phone number: ✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-289-799-****
Website: fusionpharma.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: FUSN
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2014
Employees: 51-200

Media & News

Funding & Financials

$60M
Fusion Pharmaceuticals has raised a total of $60M of funding over 5 rounds. Their latest funding round was raised on Feb 13, 2023 in the amount of $60M.
$10M
Fusion Pharmaceuticals's revenue is in the range of $10M

Funding & Financials

$60M
Fusion Pharmaceuticals has raised a total of $60M of funding over 5 rounds. Their latest funding round was raised on Feb 13, 2023 in the amount of $60M.
$10M
Fusion Pharmaceuticals's revenue is in the range of $10M

Company Leadership

C. L.
Chief Scientific Officer
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. B.
Chief Medical Officer
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. B.
Chief Technical Officer
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. C.
Chief Financial Officer
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. S.
Chief Legal Officer
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

M. S.
Chief Legal Officer
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. D. M.
Owner
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
E. O. T.
Vice President, Head Of Regulatory Affairs
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. B.
Sr. Dir. Safety & Pharmacovigilance, Head Of Safety
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. R.
Vice President Of Quality
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Fusion Pharmaceuticals and Millions of Other Companies
Sign up for full access to Fusion Pharmaceuticals information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Fusion Pharmaceuticals

Curis

Magenta Therapeutics

NuCana plc

Molecular Templates

Fusion Pharmaceuticals Tech Stack

Media & News

AstraZeneca India Private Limited acquires Fusionpharma.

Fusionpharma launches FPI-2265.

EQT acquires Fusionpharma.

Fusionpharma has issues with : employee rights.

AstraZeneca group acquires Fusionpharma for $2.4B.

AstraZeneca acquires Fusionpharma for $2B.

Imfinzi acquires Fusionpharma for $2.4B.

Fusion Pharmaceuticals's Email Address Formats

Frequently Asked Questions

Where is Fusion Pharmaceuticals's headquarters located?

What is Fusion Pharmaceuticals's phone number?

What is Fusion Pharmaceuticals's stock symbol?

What is Fusion Pharmaceuticals's official website and social media links?

How much revenue does Fusion Pharmaceuticals generate?

What is Fusion Pharmaceuticals's SIC code NAICS code?

How many employees does Fusion Pharmaceuticals have currently?

What industry does Fusion Pharmaceuticals belong to?

What technology does Fusion Pharmaceuticals use?

What is Fusion Pharmaceuticals's email format?

How much funding has Fusion Pharmaceuticals raised to date?

When was Fusion Pharmaceuticals founded?

Fusion Pharmaceuticals

Company Overview

Media & News

AstraZeneca India Private Limited acquires Fusionpharma.

Fusionpharma launches FPI-2265.

EQT acquires Fusionpharma.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?